Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell-surface attachment factors are a heterogeneous group of molecules, including heparan sulfate proteoglycans (HSPGs), sialic acids, and other glycoconjugates, that mediate the initial, often low-affinity, adherence of pathogens to host cells (Maginnis, 2018 [4]). These factors act as a molecular velcro, concentrating viruses, bacteria, or parasites on the cell membrane to facilitate subsequent binding to specific, high-affinity entry receptors that trigger internalization (Cagno et al., 2019 [1]). For instance, many viruses like Herpes Simplex Virus (HSV) and SARS-CoV-2 utilize HSPGs for initial docking before engaging more specific protein receptors (Clausen et al., 2020 [2]). Because these attachment factors are frequently shared across multiple pathogen species, they are significant targets for the development of broad-spectrum entry inhibitors. Therapeutic strategies often involve the use of polyanionic compounds or lectins that mask these attachment sites or neutralize the pathogen's binding proteins, thereby preventing the establishment of infection at the earliest stage (O'Keefe et al., 2009 [3]). Beyond infection, these factors also play roles in cancer metastasis and inflammation by facilitating cell-to-cell and cell-to-matrix interactions.
Drugs targeting host cell-surface attachment factors typically function as competitive inhibitors or molecular decoys that mimic the structure of the host factor, thereby binding to the pathogen's surface proteins and preventing their interaction with the actual cell surface (Maginnis, 2018 [4]; Cagno et al., 2019 [1]).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell-surface attachment factors.